EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating bioinformatic analysis and detailed experiments reveal an EMT ‐related biomarker for clear cell renal cell carcinoma

Yue Ge, Sheng Ma, Junbiao Zhang, Zezhong Xiong, Beining Li, Siquan Ma, Bo Liu iD, Xiangyang Yao, Zhihua Wang iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Yue Ge und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Epithelial-Mesenchymal Transition, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epithelial–mesenchymal transition (EMT) is associated with early recurrence and a poor prognosis in clear cell renal cell carcinoma (ccRCC). Studies have shown that EMT‐related genes play an important regulatory role in tumor invasion, metastasis, and drug resistance, but the biological functions of EMT‐related genes in ccRCC have not been specifically described.

Methods

The mRNA and clinicopathological data of 532 ccRCC and 72 normal samples were downloaded from The Cancer Genome Atlas as a training set. The gene expression matrix and survival data of 91 and 101 ccRCC samples were obtained from the International Cancer Genome Consortium and the ArrayExpress databases as validation sets, respectively. Univariate Cox analysis was used to identify and cluster prognostic genes, and multivariate Cox was performed to construct a prognostic signature. Moreover, CIBERSORT and CellMiner were used to assess immune cell infiltration and prognostic gene‐drug sensitivity of the signature, respectively. Most importantly, we performed detailed experiments to verify the oncogenic function of a significant gene, OLFML2B, in vitro and in vivo.

Results

We constructed a prognostic signature including seven genes and divided patients into high‐risk and low‐risk groups. The prognosis of the high‐risk group was significantly worse than that of the low‐risk group through Kaplan–Meier survival analysis. Interestingly, significant differences were observed in clinical characteristics and immune cell infiltration between the two groups. In addition, a significant correlation was found between the expression of prognostic genes and the sensitivity of tumor cells to chemotherapeutics. Most importantly, OLFML2B was proved to contribute to the proliferation and metastasis of ccRCC through detailed functional experiments in vitro and in vivo, and its prognostic efficacy for ccRCC patients was affirmed.

Conclusion

We identified the prognostic signature of seven genes based on EMT‐related genes as prognostic biomarkers for ccRCC. Besides, OLFML2B was validated as a potential diagnostic and therapeutic target for ccRCC by our detailed experiments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellEpithelial-Mesenchymal TransitionKidney NeoplasmsBiomarkers, TumorComputational BiologyHumansPrognosisFemaleMaleAnimalsGene Expression Regulation, NeoplasticMiceGene Expression ProfilingMiddle AgedCell Line, Tumor

Stichwörter der Autor:innen

OLFML2Bbiomarkerclear cell renal cell carcinomaepithelial-mesenchymal transition

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.

ORCID-Profile: Bo Liu, Zhihua Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ge, Y., Ma, S., Zhang, J., Xiong, Z., Li, B., Ma, S., Liu, B., Yao, X., & Wang, Z. (2023). Integrating bioinformatic analysis and detailed experiments reveal an EMT ‐related biomarker for clear cell renal cell carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.6504

Vancouver

Ge Y, Ma S, Zhang J, Xiong Z, Li B, Ma S, et al. Integrating bioinformatic analysis and detailed experiments reveal an EMT ‐related biomarker for clear cell renal cell carcinoma. Cancer Medicine. 2023. doi:10.1002/cam4.6504

BibTeX
@article{Ge2023,
  author = {Ge, Yue and Ma, Sheng and Zhang, Junbiao and Xiong, Zezhong and Li, Beining and Ma, Siquan and Liu, Bo and Yao, Xiangyang and Wang, Zhihua},
  title = {Integrating bioinformatic analysis and detailed experiments reveal an EMT ‐related biomarker for clear cell renal cell carcinoma},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6504}
}
Kostenlos starten →